Skip to main content

Table 4 Adverse Events Caused with Treatments (n (%))

From: Liraglutide and Metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease

Adverse Events Section 1 Section 2
Liraglutide monotherapy
n = 30
Metformin monotherapy
n = 30
P Liraglutide (1.8 mg/d) monotherapy
n = 30
Liraglutide plus Metformin dual therapy
n = 30
P
Transient anorexia, nausea or vomit 5 (16.7) 7 (23.3) 0.519 6 (20.0) 14 (46.7) 0.029
Transient diarrhea 2 (6.7) 2 (6.7) 1.000 3 (10.0) 1 (3.3) 0.612
Hypoglycemia 1 (3.3) 1 (3.3) 1.000 4 (13.3) 3 (10.0) 1.000
Injection site skin induration and irritation 1 (3.3) 0 (3.3) 0.313 1 (3.3) 2 (6.7) 1.000